Back to Search
Start Over
Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study
- Source :
- The Journal of thoracic and cardiovascular surgery. 131(2)
- Publication Year :
- 2005
-
Abstract
- Objectives Improvement in health-related quality of life is a major object of cardiac surgery. However, high stress exposure during the perioperative period of cardiac surgery can result in the formation of traumatic memories and symptoms of chronic stress or even posttraumatic stress disorder, which can have negative effects on health-related quality-of-life outcome. In this controlled study we examined whether exogenously administered stress doses of hydrocortisone during cardiac surgery reduce perioperative stress exposure and the long-term incidence of chronic stress symptoms and improve health-related quality of life after cardiac surgery. Methods Thirty-six high-risk patients undergoing cardiac surgery were prospectively randomized to receive either stress doses of hydrocortisone or placebo. Of 28 available patients at 6 months after cardiac surgery, 14 had received hydrocortisone, and 14 had received placebo. Traumatic memories, chronic stress symptoms (posttraumatic stress disorder scores), and health-related quality of life were measured by using validated questionnaires. Results Compared with patients from the placebo group, patients from the hydrocortisone group had a significantly shorter duration of intensive care unit treatment, required lower doses of the stress hormone norepinephrine during cardiac surgery, and had significantly fewer stress symptoms and a better health-related quality of life regarding physical function, chronic pain, general health, vitality, and mental health during follow-up. The groups did not differ with regard to the number or type of intensive care unit–related traumatic memories. Conclusions The use of stress doses of hydrocortisone in high-risk cardiac surgical patients reduces perioperative stress exposure, decreases chronic stress symptoms, and improves health-related quality of life at 6 months after cardiac surgery.
- Subjects :
- Pulmonary and Respiratory Medicine
Male
medicine.medical_specialty
SF-36
Hydrocortisone
610 Medicine & health
Placebo
2705 Cardiology and Cardiovascular Medicine
law.invention
Stress Disorders, Post-Traumatic
Double-Blind Method
law
Risk Factors
Intensive care
medicine
Humans
Chronic stress
Cardiac Surgical Procedures
Aged
business.industry
Chronic pain
Perioperative
11359 Institute for Regenerative Medicine (IREM)
Middle Aged
medicine.disease
Intensive care unit
Surgery
2746 Surgery
2740 Pulmonary and Respiratory Medicine
Anesthesia
Quality of Life
Female
business
Cardiology and Cardiovascular Medicine
Stress, Psychological
medicine.drug
Subjects
Details
- ISSN :
- 1097685X
- Volume :
- 131
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- The Journal of thoracic and cardiovascular surgery
- Accession number :
- edsair.doi.dedup.....b490c48d65667a767c12f55369fb8954